Literature DB >> 23640994

Blocking direct inhibitor bleeding.

Carolyn M Millar1, David A Lane.   

Abstract

In this issue of Blood, Schiele et al report the development of a monoclonal antibody that reverses the anticoagulant effect of the direct thrombin inhibitor dabigatran.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23640994     DOI： 10.1182/blood-2013-03-489864

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Newer clinically available antithrombotics and their antidotes.

Authors:  Samuel Lévy
Journal:  J Interv Card Electrophysiol       Date:  2014-06-18       Impact factor: 1.900

2.  The epidemic of pre-injury oral antiplatelet and anticoagulant use.

Authors:  A E Berndtson; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-05-01       Impact factor: 3.693

Review 3.  Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.

Authors:  Pierre Sié
Journal:  Drug Des Devel Ther       Date:  2016-05-18       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.